: For years, treatment options for advanced gynecological malignancies have been limited, with the combination of carboplatin and paclitaxel being the preferred first-line therapeutic approach, regardless of disease type [...].

Farolfi, A., Montanari, D., Casadei, C., Musolino, A. (2025). Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors. BIOMEDICINES, 13(2), 1-4 [10.3390/biomedicines13020528].

Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors

Farolfi A.;Casadei C.;Musolino A.
Ultimo
2025

Abstract

: For years, treatment options for advanced gynecological malignancies have been limited, with the combination of carboplatin and paclitaxel being the preferred first-line therapeutic approach, regardless of disease type [...].
2025
Farolfi, A., Montanari, D., Casadei, C., Musolino, A. (2025). Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors. BIOMEDICINES, 13(2), 1-4 [10.3390/biomedicines13020528].
Farolfi, A.; Montanari, D.; Casadei, C.; Musolino, A.
File in questo prodotto:
File Dimensione Formato  
biomedicines-13-00528.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 171.47 kB
Formato Adobe PDF
171.47 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1009366
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact